ArticleJournal of the American Academy of Dermatology2023

Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma.

Michael R Stephens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.